5‐Fluorouracil permits access to a primitive subpopulation of peripheral blood stem cells
- 1 January 1993
- journal article
- review article
- Published by Oxford University Press (OUP) in The International Journal of Cell Cloning
- Vol. 11 (4) , 326-335
- https://doi.org/10.1002/stem.5530110411
Abstract
Peripheral blood stem cells (PBSC) contain a mixture of mature and immature hematopoietic progenitors. Resistance to 5-Fluorouracil (S-FU) has been used to identify and characterize primitive quiescent stem cells among bone marrow (BM) cells. To see if the same technique could be used to isolate a similar population of cells among PBSC, low-density peripheral blood mononuclear cells (PBMNC) were collected by cytapheresis in the regenerative phase after high-dose chemotherapy from patients with hematological malignancies. These PBMNC were incubated with increasing concentrations of 5-FU for 24 h. The viable 5-FU resistant cells were then cultured in semi-solid media in the presence of either single cytokines: TCM 5637, Granulocyte Macrophage Colony Stimulating Factor (GM-CSF), or a combination of cytokines: interleukin 1 (IL-1) IL-l+IL-3+5637, IL-l+IL-3+Stem Cell Factor (SCF). Low concentrations (5-10 μg/ml S-FU) eliminated mature day 7 Colony Forming Units-Granulocyte Macrophage (CFU-GM) and spared day 7 clusters while enriching for day 14 CFU-GM, irrespective of the growth factors used. Higher concentrations of 5-FU (15, 20, 25 μg/ml) selected for later forming clonogenic elements. A combination of synergistic growth factors was required for the development of morphologically identifiable clonogenic elements resistant to 25 μg/ml 5-FU at day 21 of culture. Further experimentation demonstrated that SCF could effectively replace TCM 5637 in the cytokine combination for the detection of primitive late forming clonogenic elements. The presence of SCF potentiated colony formation by 5-FU resistant PBMNC. It was confirmed that GM-CSF alone was unable to support colony formation by PBMNC resistant to 25μg/ml. These observations demonstrate that PBSC contain a heterogenous mixture of hematopoietic progenitors and that incubation with 25 μg/ml 5-FU permits access to a quiescent primitive stem cell population that requires a combination of synergistic growth factors for the development of morphologically identifiable clonogenic elements at day 21. Taken together, these results suggest that PBSC have similar characteristics to BM derived stem cells.Keywords
This publication has 20 references indexed in Scilit:
- Peripheral stem cells made to workThe Lancet, 1992
- Mobilized Blood Stem Cells: Immunophenotyping and Functional CharacteristicsJournal of Hematotherapy, 1992
- Peripheral blood The International Journal of Cell Cloning contain pluripotent cellsThe International Journal of Cell Cloning, 1992
- Blood-derived haematopoietic cell transplants: blood to blood?The Lancet, 1991
- Purified primitive human hematopoietic progenitor cells with long-term in vitro repopulating capacity adhere selectively to irradiated bone marrow stroma.The Journal of Experimental Medicine, 1990
- Characterization of a human hematopoietic progenitor cell capable of forming blast cell containing colonies in vitro.Journal of Clinical Investigation, 1988
- High levels of circulating haemopoietic stem cells in very early remission from acute non‐lymphoblastic leukaemia and their collection and cryopreservationBritish Journal of Haematology, 1984
- Studies of hematopoietic stem cells spared by 5-fluorouracil.The Journal of Experimental Medicine, 1984
- Collagen gels as a matrix for haemopoiesisJournal of Cellular Physiology, 1981
- Limited potential of circulating haemopoietic stem cellsNature, 1975